| abstract |
The present invention relates to a vasodilator active agent selected from the group comprising Brazilian ginseng ( Pfaffia glomerata ), Siberian ginseng ( Eleutherococcus senticosus) , Korean red ginseng ( Panax ginseng ), American ginseng ( Panax quinquefolius ), maca ( Lepidium meyenii ), guarana ( Paullinia cupana ), caffeine, theine, muira puama ( Ptychopetalum olacoides ), silver apricot ( Ginkgo biloba ), yohimbe ( Pausinystalia johimbe ), tribulus (Tribulus terrestris) , ginger ( Zingiber officinale ), cinnamon ( Cinnamomum verum ), celery ( Apium graveolens ) and mixtures thereof, and preferably Brazilian ginseng, in combination with hyaluronic acid and / or its salts, and optionally with a moisturizing agent chosen from the group comprising heparan sulphates, glycerol, an anionic polysaccharide (Biosaccharide gum-1), xylitol, fructose, collagen, a triple ester of glycerol and caprylic and capric acids (name INCI: caprilic / capric triglycerides), caprylyl caprylate / caprate (INCI name), nicotinamide, Aloe vera ( Aloe barbadensis ) and mixtures thereof, and preferably heparan sulphates, for use in the prevention and / or treatment of somesthesia disorders, and more particularly hypoesthesia. |